Fayez Sarofim & CO Astrazeneca PLC Transaction History
Fayez Sarofim & CO
- $41.7 Billion
- Q3 2025
A detailed history of Fayez Sarofim & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Fayez Sarofim & CO holds 3,894,437 shares of AZN stock, worth $348 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
3,894,437
Previous 3,745,902
3.97%
Holding current value
$348 Million
Previous $262 Million
14.14%
% of portfolio
0.72%
Previous 0.65%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...